Updates on the pathogenicity status of Pseudomonas aeruginosa

MW Azam, AU Khan - Drug discovery today, 2019 - Elsevier
Highlights•MDR P. aeruginosa is one of the major causes of the nosocomial
infections.•Virulence factors involved in pathogenicity were described.•Potential inhibitors of …

Combination therapy for treatment of infections with gram-negative bacteria

PD Tamma, SE Cosgrove… - Clinical microbiology …, 2012 - Am Soc Microbiol
Combination antibiotic therapy for invasive infections with Gram-negative bacteria is
employed in many health care facilities, especially for certain subgroups of patients …

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta …

D Nathwani, G Raman, K Sulham, M Gavaghan… - … resistance and infection …, 2014 - Springer
Background Increasing rates of resistant and multidrug-resistant (MDR) P. aeruginosa in
hospitalized patients constitute a major public health threat. We present a systematic review …

Ventilator-associated pneumonia

J Chastre, JY Fagon - American journal of respiratory and critical …, 2002 - atsjournals.org
Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of
patients receiving mechanical ventilation (MV). In contrast to infections of more frequently …

Burn wound infections

D Church, S Elsayed, O Reid, B Winston… - Clinical microbiology …, 2006 - Am Soc Microbiol
Burns are one of the most common and devastating forms of trauma. Patients with serious
thermal injury require immediate specialized care in order to minimize morbidity and …

Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes

EB Hirsch, VH Tam - Expert review of pharmacoeconomics & …, 2010 - Taylor & Francis
Rates of antibiotic resistance in Pseudomonas aeruginosa are increasing worldwide. The
multidrug-resistant (MDR) phenotype in P. aeruginosa could be mediated by several …

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

GH Talbot, J Bradley, JE Edwards Jr… - Clinical infectious …, 2006 - academic.oup.com
Abstract The Antimicrobial Availability Task Force (AATF) of the Infectious Diseases Society
of America (IDSA) has viewed with concern the decreasing investment by major …

Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India

M Akram, M Shahid, AU Khan - Annals of clinical microbiology and …, 2007 - Springer
Abstract Background Urinary tract infections (UTIs) remain the common infections diagnosed
in outpatients as well as hospitalized patients. Current knowledge on antimicrobial …

Versatility of aminoglycosides and prospects for their future

SB Vakulenko, S Mobashery - Clinical microbiology reviews, 2003 - Am Soc Microbiol
Aminoglycoside antibiotics have had a major impact on our ability to treat bacterial infections
for the past half century. Whereas the interest in these versatile antibiotics continues to be …

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

CG Giske, DL Monnet, O Cars… - Antimicrobial agents and …, 2008 - Am Soc Microbiol
During the last decade, the efforts to combat multidrugresistant (MDR) microorganisms
mainly focused on gram-positive bacteria, namely, methicillin-resistant Staphylococcus …